Joseph F. Lovett (Chairman)
Joe Lovett is managing general partner at Louisiana Fund I. Mr. Lovett serves as Chairman of the Board of Esperance Pharmaceuticals, Inc. He has over 36 years of experience in the life science field and has extensive experience managing venture capital funds. He holds a B.A in economics from the University of Vermont and an MBA from California State Polytechnic University.
Ross P. Barrett
Ross Barrett is managing general partner at Themelios Venture Partners and is also a Partner at VCE Capital. His expertise includes risk assessment and regulatory reform. Mr. Barrett received a B.A. in Political Science from Southern Methodist University, and a J.D. from Louisiana State University School of Law. He also earned a masters degree in taxation from New York University School of Law.
Hector Alila, Ph.D.
Hector Alila is Founder, President, and C.E.O of Esperance Pharmaceuticals. Dr. Alila is a biopharmaceutical industry veteran bringing over 20 years of management, drug development, and research experience in large pharmaceutical and biotech industry to Esperance. He served as Senior Vice President of Drug Development at Protalex, Inc. (New Hope, PA), Vice President of Product Development at Cell Pathways, Inc. in Horsham, PA, (later acquired by OSI Pharmaceuticals), Director of Biology/Pharmacology at GeneMedicine, Inc. in The Woodlands, TX, (which merged with Megabios to become Valentis Inc.) and several research, development, and management positions at SmithKline Beecham (now GlaxoSmithKline) in PA. He obtained his Ph.D. degree in physiology and immunology from Cornell University (Ithaca, NY).
Brett P. Giroir, MD
Dr. Giroir is an internationally recognized physician scientist and currently CEO of Health Science and Biosecurity Partners, LLC. He has held numerous influential positions in both academia and the federal government, including CEO of the Texas A&M Health Science Center, Director of the Defense Science Office at DARPA, Professor and Associate Dean at UT Southwestern Medical Center, and Chief Medical Officer at Children’s Health, Dallas. Dr. Giroir has led numerous national and state initiatives, including chairing the Congressional Choice Act Blue Ribbon Panel to assess and reform the Veterans Health Administration, the Texas Task Force to respond to the Ebola outbreak in Dallas, and the ~$3 billion public-private partnership with the US Department of Health and Human Services to establish a national Center for Innovation in Advanced Development and Manufacturing in Texas. Dr. Giroir is the recipient of the US Secretary of Defense Medal for Outstanding Public Service and the Texas A&M System Award for Innovation. Dr. Giroir received his undergraduate degree from Harvard University, and his medical degree from UT Southwestern Medical Center in Dallas.